Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: B.REVERE who wrote (4217)	7/10/1998 6:09:00 PM
From: Frank Murphy	Read Replies (2) \| Respond to of 9523

Thread: I am also a trial member and promise not to be as irresponsible as The Johnson. I have designed networks for Pfizer and am looooong it as well. I deeply appreciate all of the work Anthony, BigKNY3, Zurdo, B. Revere and the rest. Cosmo cracks me up. Wonder how "Hot Tuna" feels now....... Hope to add useful info when appropriate. Thanx all 4 the informative posts and hope to contribute. FM

To: B.REVERE who wrote (4217)	7/10/1998 7:09:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

BR, is the report referred to by Everen Securites? <Management reduced this figure by moving more R&D expense into this quarter's report. This accounted for about 6 cents of the 12 cent reduction.> In any case, this seems a wise move on the part of Pfizer management. Viagra sales in Q2 is strong because of pent-up demand, but Q3 may not be as strong if new scripts levels off (though off-set in part by strong re-fill numbers). In Q4 we have European sales and hopefully Canadian sales kicking in, so that should be OK. I really have to print out the earnings report for a more detailed reading this weekend. Anthony